Rheumatoid factors in rheumatoid arthritis and vasculitis. 1985

M L Westedt, and P Herbrink, and J L Molenaar, and E de Vries, and P Verlaan, and T Stijnen, and A Cats, and J Lindeman

To study the occurrence of rheumatoid factors (RF) in relation to the activity of rheumatoid arthritis and the occurrence of vasculitis, RF of IgM, IgA, and IgG classes were measured in sera from 35 patients with definite or classic rheumatoid arthritis (RA) using ELISA. For 26 patients, the RF levels were studied longitudinally and compared with changes in the articular index. Although IgM RF was occasionally found in patients without RA, IgA and/or IgG RF were almost exclusively associated with RA. The titers of IgM, IgA, and IgG RF were significantly higher in sera from patients with clinically diagnosed rheumatoid vasculitis than in sera from patients without vasculitis. No significant correlation between changes in the articular index and changes in titer of any class-specific RF could be found for the group of RA patients as a whole. However, in individual patients, increases or decreases in IgM and IgG RF titer were significantly correlated with an increase or decrease in the articular index.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005189 False Positive Reactions Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed) False Positive Reaction,Positive Reaction, False,Positive Reactions, False,Reaction, False Positive,Reactions, False Positive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M L Westedt, and P Herbrink, and J L Molenaar, and E de Vries, and P Verlaan, and T Stijnen, and A Cats, and J Lindeman
July 1996, Orvosi hetilap,
M L Westedt, and P Herbrink, and J L Molenaar, and E de Vries, and P Verlaan, and T Stijnen, and A Cats, and J Lindeman
May 1994, Current opinion in rheumatology,
M L Westedt, and P Herbrink, and J L Molenaar, and E de Vries, and P Verlaan, and T Stijnen, and A Cats, and J Lindeman
January 2009, Current opinion in rheumatology,
M L Westedt, and P Herbrink, and J L Molenaar, and E de Vries, and P Verlaan, and T Stijnen, and A Cats, and J Lindeman
October 1985, Nihon rinsho. Japanese journal of clinical medicine,
M L Westedt, and P Herbrink, and J L Molenaar, and E de Vries, and P Verlaan, and T Stijnen, and A Cats, and J Lindeman
December 1976, Proceedings of the Royal Society of Medicine,
M L Westedt, and P Herbrink, and J L Molenaar, and E de Vries, and P Verlaan, and T Stijnen, and A Cats, and J Lindeman
April 2013, Presse medicale (Paris, France : 1983),
M L Westedt, and P Herbrink, and J L Molenaar, and E de Vries, and P Verlaan, and T Stijnen, and A Cats, and J Lindeman
January 1978, Revista espanola de reumatismo y enfermedades osteoarticulares,
M L Westedt, and P Herbrink, and J L Molenaar, and E de Vries, and P Verlaan, and T Stijnen, and A Cats, and J Lindeman
December 2014, QJM : monthly journal of the Association of Physicians,
M L Westedt, and P Herbrink, and J L Molenaar, and E de Vries, and P Verlaan, and T Stijnen, and A Cats, and J Lindeman
April 1975, Archives of neurology,
M L Westedt, and P Herbrink, and J L Molenaar, and E de Vries, and P Verlaan, and T Stijnen, and A Cats, and J Lindeman
May 1981, British medical journal (Clinical research ed.),
Copied contents to your clipboard!